XiaoMi-AI文件搜索系统
World File Search Systemcirculation
建筑论坛 - USModernist
建筑论坛 第 133 卷133 期17/8 月刊。每年出版 10 期，总发行量约 100 万。1 月/2 月。和 7/8 月。期刊，订阅费为 12 美元，由 Whitney Publications, Inc. 出版，美国和加拿大境内。130 East .59th St., New York, N.Y. 10022。其他地方，20 美元。大学学生费率 免费发送给在美国和加拿大注册的美国建筑师和教职员工。加拿大认可的合格人员学校允许撰写建筑论文，6 美元。单份，1.50 美元。以商业出版物公司信笺为抬头的 Circulation 封面。请向 Circulation, Inc. 的主要审计机构说明建筑注册状态、已付控制发行邮资、您的头衔以及您从事的工作类型。纽约，纽约有关 Whitney Publications, Inc. 51970 服务、地址变更等的信函应发送 保留所有权利。
靶向邻育素-2进行心力衰竭基因治疗
传记：朗兴（Long-Sheng）博士是爱荷华大学卡佛大学医学院（University of Iowa Carver College）心血管研究的教授兼伊迪丝·金·皮尔森（Edith King Pearson）主席。宋博士是国际心脏研究学会的当选研究员，是心脏激发 - 收缩（E-C）耦合方面的领先专家。他在高影响力期刊上撰写了120多个同行评审的出版物，包括科学，自然，细胞，流通等。他的研究为了解健康和疾病（包括心力衰竭和心律不齐）的E-C耦合做出了重大贡献。Notably, Dr. Song's work uncovered how ultrastructural remodeling of cardiomyocyte T-tubule system contributes to E-C coupling dysfunction and heart failure (PNAS, 2006) and how these changes are linked to the dysregulation of junctophilin-2, a key structural protein in E-C coupling (Circulation Research, 2010; PNAS, 2014; Circulation, 2014).在其具有里程碑意义的2018年科学论文中，Song博士证明了Calpain裂开的N末端片段的N末端片段可作为应激自适应的转录调节剂，可以防止在压力心脏中进行转录重编程和病理重塑。这一发现为心力衰竭的精确医学和有针对性的治疗策略开辟了新的途径（Circulation Research，2022； Cockulation，2024）。此外，Song的研究还提高了对心律不齐的理解，包括心房颤动（循环，2023； Heart Rhythm，2024），心律失常右心肌病（循环，2020年）和儿童素疗法多肌膜多态性的心态心态循环。
首次在患有心肌病的转甲状腺素蛋白 (ATTR) 淀粉样变性患者体内使用 NTLA-2001 对 TTR 基因进行 CRISPR/Cas9 编辑
QoL，生活质量；Donnelly JP、Hanna M. Cleve Clin J Med 2017；84:12–26 Lane T 等人。Circulation 2019；140:16–26 Pinney JH 等人。J Am Heart Assoc 2013；2:e000098 Rowczenio D 等人。Orphanet J Rare Dis 2017；12（补充 1）：165；摘要 P1
cns详细时间表
-Introduction -Spinal cord 1 -Spinal cord 2 -Spinal cord 4 -Brain stem 1 -Brain stem 2 -General histology and Gross anatomy of the cerebrum -Functional areas (Broadman's classification) and their lesions -Ventricular system 1 (Anatomy of lateral and third ventricle) -Ventricular system 2 (Anatomy of the fourth ventricle and CSF circulation) -Anatomy of human CEREBELLUM-中枢神经系统的供应和病变的作用
心血管系统（CVS）模块第一专业...
vessels 2) Describe the steps of development of the heart 3) Describe the steps of development of arterial, venous and lymphatic system 4) Describe the conduction system of the heart 5) Describe the anatomy of valves of the heart 6) Describe the microscopic structure of myocardium, and blood vessels 7) Describe the cardiac cycle 8) Discuss cardiac output, and venous return 9) Discuss blood pressure and its regulation 10) Discuss coronary circulation and diseases associated with 11）描述循环冲击的机理和类型
糖尿病的目标课程计划
Q：哪些器官可能会受到糖尿病的影响？ 短期还是长期？ In pairs come up with a list of what can be affected Short: skin (spots and infections), brain (concentration), blurred vision, headaches, UTIs Long: eyes, feet, nerves, circulation, kidneys, heart, blood vessels, reproductive health - fertility and ED Use body board or pre-drawn body on flip chart to identify the above – invite pairs to feedback Educator to explain the potential effects of long term diabetes,并将AR检查与不同的器官联系（作为任何长期效果的筛选方式，以便提早标记任何问题）Q：哪些器官可能会受到糖尿病的影响？短期还是长期？In pairs come up with a list of what can be affected Short: skin (spots and infections), brain (concentration), blurred vision, headaches, UTIs Long: eyes, feet, nerves, circulation, kidneys, heart, blood vessels, reproductive health - fertility and ED Use body board or pre-drawn body on flip chart to identify the above – invite pairs to feedback Educator to explain the potential effects of long term diabetes,并将AR检查与不同的器官联系（作为任何长期效果的筛选方式，以便提早标记任何问题）
LWW Total Access Journal Collection
护理•循环•循环研究•循环：心律失常和电生理学•循环：心血管成像•循环•循环：心血管干预•循环•循环：心血管质量和结局•循环•循环•循环•精确医学•循环•心脏失败•临床临床医学•临床临床杂志•临床杂志•临床杂志•医学•临床护士专家•临床营养洞察*•临床妇产科•临床骨科和相关研究•临床肺医学*•临床脊柱手术•认知和行为神经病学•认知和行为神经病学•当代重症监护*•当代诊断•当代诊断•当代疗法•当代疗法* • CONTINUUM: Lifelong Learning in Neurology • Cornea • Coronary Artery Disease • Critical Care Medicine • Critical Care Nursing Quarterly • Critical Pathways in Cardiology • Current Opinion in Allergy and Clinical Immunology • Current Opinion in Anesthesiology • Current Opinion in Cardiology • Current Opinion in Clinical Nutrition & Metabolic Care • Current Opinion in Critical Care • Current Opinion in Endocrinology, Diabetes and Obesity • Current Opinion in Gastroenterology •血液学目前的意见•当前的艾滋病毒和艾滋病意见•当前的传染病意见•脂肪学目前的意见•当前的肾脏学和高血压中的意见•当前的神经病学•当前的妇产科意见
高风险同种异体或自体BMT或白血病患者的病毒呼吸道感染的诊断和管理
Contents Scope ..................................................................................................................................................... 2 1.Introduction ................................................................................................................................ 2 1.1.High-risk criteria ........................................................................................................................ 2 2.Diagnosis .................................................................................................................................... 2 2.1.Samples ................................................................................................................................... 2 2.2.Investigations ............................................................................................................................ 2 3.Minimising infection spread ...................................................................................................... 3 3.1.Inpatients .................................................................................................................................. 3 3.2.Inpatient visitors/relatives .......................................................................................................... 3 3.3.Outpatients ............................................................................................................................... 3 3.4.Staff .......................................................................................................................................... 3 3.5.Staff illness ............................................................................................................................... 4 3.6.Environment or equipment ........................................................................................................ 4 4.Management ............................................................................................................................... 4 4.1.Respiratory Syncytial Virus (RSV)........................................................................................ 4 4.2.Investigations ............................................................................................................................ 4 4.3.Treatment criteria ...................................................................................................................... 4 4.4.Treatment algorithm .................................................................................................................. 5 4.5.Immunoglobulin for RSV – post BMT patients only ................................................................... 5 4.6.Ribavirin (unlicensed) ............................................................................................................... 6 4.7.Influenza A & B ...................................................................................................................... 7 4.8.Investigations ............................................................................................................................ 7 4.9.Treatment ................................................................................................................................. 7 4.10.Parainfluenza (HPIV) ............................................................................................................. 7 4.11.Parainfluenza的免疫球蛋白 - 仅BMT后患者................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... 7 4.12。Adenovirus ............................................................................................................................. 8 4.13.Cidofovir (micro approval required) ....................................................................................... 8 4.14.SARS-CoV-2 ........................................................................................................................... 9 References ............................................................................................................................................ 9 Original authors .................................................................................................................................. 10 Audit .................................................................................................................................................... 10 Circulation ........................................................................................................................................... 10 Review ................................................................................................................................................. 11
心肌炎最新进展
* https://www.cdc.gov/vaccines/acip/meetings/index.html , https://www.cdc.gov/vaccinesafety/research/publications/index.html † Oster 等人。JAMA。2022；327:331-340。‡ Law 等人。Circulation。2021；144:e123-e135。Ghelani 等人。Circ Cardiovasc Qual Outcomes。2012；5:622-7。Kim 等人。韩国 Circ J。2020；50:1013-1022。Messroghli 等人。Am Heart J。2017；187:133-144。Patel 等人。J Am Heart Assoc。2022；11:e024393。 ¶ 文献中很少有相关报道，尤其是来自其他国家的报道，但尚不清楚对此类案例的调查程度